
LINK . SPRINGER . COM {
}
Title:
The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo | Cancer Chemotherapy and Pharmacology
Description:
Purpose This study was designed to test the ability of the Bcl-2 family inhibitor ABT-263 to potentiate commonly used chemotherapeutic agents and regimens in hematologic tumor models. Methods Models of B-cell lymphoma and multiple myeloma were tested in vitro and in vivo with ABT-263 in combination with standard chemotherapeutic regimens, including VAP, CHOP and R-CHOP, as well as single cytotoxic agents including etoposide, rituximab, bortezomib and cyclophosphamide. Alterations in Bcl-2 family member expression patterns were analyzed to define mechanisms of potentiation. Results ABT-263 was additive with etoposide, vincristine and VAP in vitro in the diffuse large B-cell lymphoma line (DLBCL) DoHH-2, while rituximab potentiated its activity in SuDHL-4. Bortezomib strongly synergized with ABT-263 in the mantle cell lymphoma line Granta 519. Treatment of DoHH-2 with etoposide was associated with an increase in Puma expression, while bortezomib upregulated Noxa expression in Granta 519. Combination of ABT-263 with cytotoxic agents demonstrated superior tumor growth inhibition and delay in multiple models versus cytotoxic therapy alone, along with significant improvements in tumor response rates. Conclusions Inhibition of the Bcl-2 family of proteins by ABT-263 enhances the cytotoxicity of multiple chemotherapeutics in hematologic tumors and represents a promising addition to the therapeutic arsenal for treatment of these diseases.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {π}
- Education
- Science
- Health & Fitness
Content Management System {π}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of link.springer.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {πΈ}
We can't see how the site brings in money.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {π}
article, pubmed, google, scholar, cas, cancer, bcl, abt, lymphoma, cell, expression, apoptosis, family, multiple, res, inhibitor, vivo, bcell, resistance, cells, leukemia, chemotherapy, ackler, etoposide, blood, hematologic, myeloma, vitro, rituximab, bortezomib, diffuse, large, proteins, chronic, privacy, cookies, content, response, chemotherapeutic, scott, mitten, vincristine, activity, therapy, access, lymphocytic, ther, information, publish, research,
Topics {βοΈ}
month download article/chapter chronic lymphocytic leukaemia nonpeptidic small-molecule inhibitor rituximab-resistant lymphoma clones b-cell lymphoma apoptosis-related genes bcl2 myeloid cell leukemia-1 cancer therapy gov/statfacts/html/nhl noxa-mediated lipid peroxidation indolent b-cell drug targets small-molecule inhibitor article cancer chemotherapy acute myeloid leukemia tumor cell clearance bcl-2-related genes full article pdf bcl2 antagonist abt-737 related subjects privacy choices/manage cookies altered cell signaling kill lymphoma cells bcl-xl potentiates chemotherapy resistance resulting bh3 mimetic abt-263 bh3-mimetic abt-737 bh3 mimetic abt-737 bcl-2 family genes chemotherapy improves response bcl-2 family members mimetic abt-737 synergizes multidrug resistance phenotype hodgkin lymphoma [top acute lymphoblastic leukemia //seer bcl-2 family proteins article ackler fresh myeloma cells national cancer institute shoemaker ar hematologic tumor models rituximab-mediated apoptosis european economic area tumor response rates rapamycin act cooperatively sequester prodeath bim death receptor pathway dose-effect relationships hernandez-ilizaliturri fj
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
description:This study was designed to test the ability of the Bcl-2 family inhibitor ABT-263 to potentiate commonly used chemotherapeutic agents and regimens in hematologic tumor models. Models of B-cell lymphoma and multiple myeloma were tested in vitro and in vivo with ABT-263 in combination with standard chemotherapeutic regimens, including VAP, CHOP and R-CHOP, as well as single cytotoxic agents including etoposide, rituximab, bortezomib and cyclophosphamide. Alterations in Bcl-2 family member expression patterns were analyzed to define mechanisms of potentiation. ABT-263 was additive with etoposide, vincristine and VAP in vitro in the diffuse large B-cell lymphoma line (DLBCL) DoHH-2, while rituximab potentiated its activity in SuDHL-4. Bortezomib strongly synergized with ABT-263 in the mantle cell lymphoma line Granta 519. Treatment of DoHH-2 with etoposide was associated with an increase in Puma expression, while bortezomib upregulated Noxa expression in Granta 519. Combination of ABT-263 with cytotoxic agents demonstrated superior tumor growth inhibition and delay in multiple models versus cytotoxic therapy alone, along with significant improvements in tumor response rates. Inhibition of the Bcl-2 family of proteins by ABT-263 enhances the cytotoxicity of multiple chemotherapeutics in hematologic tumors and represents a promising addition to the therapeutic arsenal for treatment of these diseases.
datePublished:2010-01-23T00:00:00Z
dateModified:2010-01-23T00:00:00Z
pageStart:869
pageEnd:880
sameAs:https://doi.org/10.1007/s00280-009-1232-1
keywords:
ABT-263
Bcl-2
Lymphoma
Myeloma
Apoptosis
Oncology
Pharmacology/Toxicology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig4_HTML.gif
isPartOf:
name:Cancer Chemotherapy and Pharmacology
issn:
1432-0843
0344-5704
volumeNumber:66
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Scott Ackler
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:
address:
name:Abbott Park, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Michael J. Mitten
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Kelly Foster
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Anatol Oleksijew
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Marion Refici
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Stephen K. Tahir
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Yu Xiao
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Christin Tse
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:David J. Frost
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Stephen W. Fesik
affiliation:
name:Vanderbilt University School of Medicine
address:
name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
type:PostalAddress
type:Organization
type:Person
name:Saul H. Rosenberg
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Steven W. Elmore
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Alexander R. Shoemaker
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
description:This study was designed to test the ability of the Bcl-2 family inhibitor ABT-263 to potentiate commonly used chemotherapeutic agents and regimens in hematologic tumor models. Models of B-cell lymphoma and multiple myeloma were tested in vitro and in vivo with ABT-263 in combination with standard chemotherapeutic regimens, including VAP, CHOP and R-CHOP, as well as single cytotoxic agents including etoposide, rituximab, bortezomib and cyclophosphamide. Alterations in Bcl-2 family member expression patterns were analyzed to define mechanisms of potentiation. ABT-263 was additive with etoposide, vincristine and VAP in vitro in the diffuse large B-cell lymphoma line (DLBCL) DoHH-2, while rituximab potentiated its activity in SuDHL-4. Bortezomib strongly synergized with ABT-263 in the mantle cell lymphoma line Granta 519. Treatment of DoHH-2 with etoposide was associated with an increase in Puma expression, while bortezomib upregulated Noxa expression in Granta 519. Combination of ABT-263 with cytotoxic agents demonstrated superior tumor growth inhibition and delay in multiple models versus cytotoxic therapy alone, along with significant improvements in tumor response rates. Inhibition of the Bcl-2 family of proteins by ABT-263 enhances the cytotoxicity of multiple chemotherapeutics in hematologic tumors and represents a promising addition to the therapeutic arsenal for treatment of these diseases.
datePublished:2010-01-23T00:00:00Z
dateModified:2010-01-23T00:00:00Z
pageStart:869
pageEnd:880
sameAs:https://doi.org/10.1007/s00280-009-1232-1
keywords:
ABT-263
Bcl-2
Lymphoma
Myeloma
Apoptosis
Oncology
Pharmacology/Toxicology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig4_HTML.gif
isPartOf:
name:Cancer Chemotherapy and Pharmacology
issn:
1432-0843
0344-5704
volumeNumber:66
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Scott Ackler
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:
address:
name:Abbott Park, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Michael J. Mitten
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Kelly Foster
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Anatol Oleksijew
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Marion Refici
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Stephen K. Tahir
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Yu Xiao
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Christin Tse
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:David J. Frost
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Stephen W. Fesik
affiliation:
name:Vanderbilt University School of Medicine
address:
name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
type:PostalAddress
type:Organization
type:Person
name:Saul H. Rosenberg
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Steven W. Elmore
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
name:Alexander R. Shoemaker
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Chemotherapy and Pharmacology
issn:
1432-0843
0344-5704
volumeNumber:66
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:
address:
name:Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Vanderbilt University School of Medicine
address:
name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Scott Ackler
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:
address:
name:Abbott Park, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Michael J. Mitten
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Kelly Foster
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Anatol Oleksijew
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Marion Refici
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Stephen K. Tahir
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Yu Xiao
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Christin Tse
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:David J. Frost
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Stephen W. Fesik
affiliation:
name:Vanderbilt University School of Medicine
address:
name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
type:PostalAddress
type:Organization
name:Saul H. Rosenberg
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Steven W. Elmore
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
name:Alexander R. Shoemaker
affiliation:
name:Abbott Laboratories
address:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(171)
- How much revenue does https://www.springernature.com/gp/authors produce monthly?
- How much does https://link.springernature.com/home/ rake in every month?
- https://order.springer.com/public/cart income
- How much revenue does https://submission.springernature.com/new-submission/280/3 produce monthly?
- How much profit is https://www.springernature.com/gp/librarians/licensing/agc/journals making per month?
- How much revenue does http://seer.cancer.gov/statfacts/html/nhl.html bring in?
- What are the total earnings of https://doi.org/10.2165%2F00003495-200666060-00005?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16706552
- Find out how much http://scholar.google.com/scholar_lookup?&title=Rituximab%3A%20a%20review%20of%20its%20use%20in%20non-Hodgkin%E2%80%99s%20lymphoma%20and%20chronic%20lymphocytic%20leukaemia&journal=Drugs&doi=10.2165%2F00003495-200666060-00005&volume=66&pages=791-820&publication_year=2006&author=Cvetkovic%2CRS&author=Perry%2CCM earns monthly
- What's the financial outcome of https://doi.org/10.1158%2F1078-0432.CCR-07-2218?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18347166 generate?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibitors%20in%20cancer%20therapy%3A%20lessons%20from%20the%20first%20decade&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-2218&volume=14&pages=1649-1657&publication_year=2008&author=Orlowski%2CRZ&author=Kuhn%2CDJ
- How much revenue does https://doi.org/10.2146%2Fajhp070272 bring in?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18574011?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Bortezomib%3A%20a%20novel%20chemotherapeutic%20agent%20for%20hematologic%20malignancies&journal=Am%20J%20Health%20Syst%20Pharm&doi=10.2146%2Fajhp070272&volume=65&pages=1221-1231&publication_year=2008&author=Utecht%2CKN&author=Kolesar%2CJ
- What's the profit of https://doi.org/10.1532%2FIJH97.04110?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15540893 net monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=Bcl-2-related%20genes%20in%20lymphoid%20neoplasia&journal=Int%20J%20Hematol&doi=10.1532%2FIJH97.04110&volume=80&pages=205-209&publication_year=2004&author=Wei%2CMC have?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9408956
- How much does http://scholar.google.com/scholar_lookup?&title=Bcl-2%20family%20proteins%3A%20regulators%20of%20apoptosis%20and%20chemoresistance%20in%20hematologic%20malignancies&journal=Semin%20Hematol&volume=34&pages=9-19&publication_year=1997&author=Reed%2CJC bring in each month?
- https://doi.org/10.1126%2Fscience.6093263's total income per month
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6093263 is on a monthly basis
- http://scholar.google.com/scholar_lookup?&title=Cloning%20of%20the%20chromosome%20breakpoint%20of%20neoplastic%20B%20cells%20with%20the%20t%2814%3B18%29%20chromosome%20translocation&journal=Science&doi=10.1126%2Fscience.6093263&volume=226&pages=1097-1099&publication_year=1984&author=Tsujimoto%2CY&author=Finger%2CLR&author=Yunis%2CJ&author=Nowell%2CPC&author=Croce%2CCM's total income per month
- What are the total earnings of https://doi.org/10.1002%2Fajh.10139?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12210808's total income per month
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Bcl-2%20family%20of%20proteins%20in%20indolent%20B-cell%20non-Hodgkin%E2%80%99s%20lymphoma%3A%20study%20of%20116%20cases&journal=Am%20J%20Hematol&doi=10.1002%2Fajh.10139&volume=70&pages=278-282&publication_year=2002&author=Agarwal%2CB&author=Naresh%2CKN have monthly?
- Find out how much https://doi.org/10.1038%2Fsj.leu.2401168 earns monthly
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9823959 bring in each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20Bcl-2%20family%20of%20proteins%20in%20fresh%20myeloma%20cells&journal=Leukemia&doi=10.1038%2Fsj.leu.2401168&volume=12&pages=1817-1820&publication_year=1998&author=Harada%2CN&author=Hata%2CH&author=Yoshida%2CM bring in?
- How much does https://doi.org/10.1038%2F35000501 earn?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10676951's earnings
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Distinct%20types%20of%20diffuse%20large%20B-cell%20lymphoma%20identified%20by%20gene%20expression%20profiling&journal=Nature&doi=10.1038%2F35000501&volume=403&pages=503-511&publication_year=2000&author=Alizadeh%2CAA&author=Eisen%2CMB&author=Davis%2CRE produce monthly?
- Financial intake of https://doi.org/10.1111%2Fj.1365-2567.2005.02117.x
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15804279 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Bodyguards%20and%20assassins%3A%20Bcl-2%20family%20proteins%20and%20apoptosis%20control%20in%20chronic%20lymphocytic%20leukaemia&journal=Immunology&doi=10.1111%2Fj.1365-2567.2005.02117.x&volume=114&pages=441-449&publication_year=2005&author=Packham%2CG&author=Stevenson%2CFK earn?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9443402 generate monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Bcl-X%20expression%20in%20multiple%20myeloma%3A%20possible%20indicator%20of%20chemoresistance&journal=Cancer%20Res&volume=58&pages=256-262&publication_year=1998&author=Tu%2CY&author=Renner%2CS&author=Xu%2CF
- What's the financial gain of https://doi.org/10.1023%2FA%3A1007056727876?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10839193's gross income?
- See how much http://scholar.google.com/scholar_lookup?&title=Differential%20responses%20of%20Bcl-2%20family%20genes%20to%20etoposide%20in%20chronic%20myeloid%20leukemia%20K562%20cells&journal=Mol%20Cell%20Biochem&doi=10.1023%2FA%3A1007056727876&volume=206&pages=43-50&publication_year=2000&author=Fukumi%2CS&author=Horiguchi-Yamada%2CJ&author=Nakada%2CS&author=Nagai%2CM&author=Ohno%2CT&author=Yamada%2CH makes per month
- What is the monthly revenue of https://doi.org/10.1196%2Fannals.1378.009?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17384250 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Alterations%20in%20mRNA%20expression%20of%20apoptosis-related%20genes%20BCL2%2C%20BAX%2C%20FAS%2C%20caspase-3%2C%20and%20the%20novel%20member%20BCL2L12%20after%20treatment%20of%20human%20leukemic%20cell%20line%20HL60%20with%20the%20antineoplastic%20agent%20etoposide&journal=Ann%20N%20Y%20Acad%20Sci&doi=10.1196%2Fannals.1378.009&volume=1090&pages=89-97&publication_year=2006&author=Floros%2CKV&author=Thomadaki%2CH&author=Florou%2CD&author=Talieri%2CM&author=Scorilas%2CA pull in monthly?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10500812
- How profitable is http://scholar.google.com/scholar_lookup?&title=Two%20distinct%20modes%20of%20oncoprotein%20expression%20during%20apoptosis%20resistance%20in%20vincristine%20and%20daunorubicin%20multidrug-resistant%20HL60%20cells&journal=Adv%20Exp%20Med%20Biol&volume=457&pages=365-381&publication_year=1999&author=Belhoussine%2CR&author=Morjani%2CH&author=Gillet%2CR&author=Palissot%2CV&author=Manfait%2CM?
- How much revenue does https://doi.org/10.1182%2Fblood-2007-08-110445 produce monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18160669?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Bortezomib%20blocks%20Bax%20degradation%20in%20malignant%20B%20cells%20during%20treatment%20with%20TRAIL&journal=Blood&doi=10.1182%2Fblood-2007-08-110445&volume=111&pages=2797-2805&publication_year=2008&author=Liu%2CFT&author=Agrawal%2CSG&author=Gribben%2CJG?
- https://doi.org/10.1158%2F0008-5472.CAN-06-4322 income
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17545623 earns monthly
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Noxa%20up-regulation%20and%20Mcl-1%20cleavage%20are%20associated%20to%20apoptosis%20induction%20by%20bortezomib%20in%20multiple%20myeloma&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-4322&volume=67&pages=5418-5424&publication_year=2007&author=Gomez-Bougie%2CP&author=Wuilleme-Toumi%2CS&author=Menoret%2CE
- How much income does https://doi.org/10.1182%2Fblood.V99.3.1038 have?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11807010 generate?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=The%20mechanism%20of%20tumor%20cell%20clearance%20by%20rituximab%20in%20vivo%20in%20patients%20with%20B-cell%20chronic%20lymphocytic%20leukemia%3A%20evidence%20of%20caspase%20activation%20and%20apoptosis%20induction&journal=Blood&doi=10.1182%2Fblood.V99.3.1038&volume=99&pages=1038-1043&publication_year=2002&author=Byrd%2CJC&author=Kitada%2CS&author=Flinn%2CIW have monthly?
- What's https://doi.org/10.1158%2F0008-5472.CAN-07-5836's gross income?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18451170
- How much money does http://scholar.google.com/scholar_lookup?&title=ABT-263%3A%20a%20potent%20and%20orally%20bioavailable%20Bcl-2%20family%20inhibitor&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-07-5836&volume=68&pages=3421-3428&publication_year=2008&author=Tse%2CC&author=Shoemaker%2CAR&author=Adickes%2CJ generate?
- Earnings of https://doi.org/10.1158%2F1535-7163.MCT-08-0268
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18852130 pull in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=ABT-263%20and%20rapamycin%20act%20cooperatively%20to%20kill%20lymphoma%20cells%20in%20vitro%20and%20in%20vivo&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-08-0268&volume=7&pages=3265-3274&publication_year=2008&author=Ackler%2CS&author=Xiao%2CY&author=Mitten%2CMJ generate?
- Profit of https://doi.org/10.1002%2Fpbc.21433
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18085673 generate monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Initial%20testing%20%28stage%201%29%20of%20the%20BH3%20mimetic%20ABT-263%20by%20the%20pediatric%20preclinical%20testing%20program&journal=Pediatr%20Blood%20Cancer&doi=10.1002%2Fpbc.21433&volume=50&pages=1181-1189&publication_year=2008&author=Lock%2CR&author=Carol%2CH&author=Houghton%2CPJ generate?
- Revenue of https://doi.org/10.1172%2FJCI28281
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17200714 generate?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Chronic%20lymphocytic%20leukemia%20requires%20BCL2%20to%20sequester%20prodeath%20BIM%2C%20explaining%20sensitivity%20to%20BCL2%20antagonist%20ABT-737&journal=J%20Clin%20Invest&doi=10.1172%2FJCI28281&volume=117&pages=112-121&publication_year=2007&author=Del%20Gaizo%20Moore%2CV&author=Brown%2CJR&author=Certo%2CM&author=Love%2CTM&author=Novina%2CCD&author=Letai%2CA?
- What's the monthly income of https://doi.org/10.1182%2Fblood-2007-12-130781?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18591385's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=The%20BH3-only%20mimetic%20ABT-737%20synergizes%20the%20antineoplastic%20activity%20of%20proteasome%20inhibitors%20in%20lymphoid%20malignancies&journal=Blood&doi=10.1182%2Fblood-2007-12-130781&volume=112&pages=2906-2916&publication_year=2008&author=Paoluzzi%2CL&author=Gonen%2CM&author=Bhagat%2CG net monthly?
- https://doi.org/10.1182%2Fblood-2007-03-080325's revenue stream
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17536015 have monthly?
- http://scholar.google.com/scholar_lookup?&title=Activity%20of%20vincristine%2C%20L-ASP%2C%20and%20dexamethasone%20against%20acute%20lymphoblastic%20leukemia%20is%20enhanced%20by%20the%20BH3-mimetic%20ABT-737%20in%20vitro%20and%20in%20vivo&journal=Blood&doi=10.1182%2Fblood-2007-03-080325&volume=110&pages=2057-2066&publication_year=2007&author=Kang%2CMH&author=Kang%2CYH&author=Szymanska%2CB income
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15657349 make?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Preclinical%20studies%20of%20a%20nonpeptidic%20small-molecule%20inhibitor%20of%20Bcl-2%20and%20Bcl-xL%20%5B%28-%29-gossypol%5D%20against%20diffuse%20large%20cell%20lymphoma&journal=Mol%20Cancer%20Ther&volume=4&pages=13-21&publication_year=2005&author=Mohammad%2CRM&author=Wang%2CS&author=Aboukameel%2CA
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17277134 make?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Fas%20receptor%20clustering%20and%20involvement%20of%20the%20death%20receptor%20pathway%20in%20rituximab-mediated%20apoptosis%20with%20concomitant%20sensitization%20of%20lymphoma%20B%20cells%20to%20fas-induced%20apoptosis&journal=J%20Immunol&volume=178&pages=2287-2295&publication_year=2007&author=Stel%2CAJ&author=Ten%20Cate%2CB&author=Jacobs%2CS
- See how much https://doi.org/10.1016%2F0065-2571%2884%2990007-4 makes per month
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6382953
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Quantitative%20analysis%20of%20dose-effect%20relationships%3A%20the%20combined%20effects%20of%20multiple%20drugs%20or%20enzyme%20inhibitors&journal=Adv%20Enzyme%20Regul&doi=10.1016%2F0065-2571%2884%2990007-4&volume=22&pages=27-55&publication_year=1984&author=Chou%2CTC&author=Talalay%2CP produce monthly?
- Find out how much https://doi.org/10.1158%2F0008-5472.CAN-06-0367 earns monthly
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16951189?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=A%20small-molecule%20inhibitor%20of%20Bcl-xL%20potentiates%20the%20activity%20of%20cytotoxic%20drugs%20in%20vitro%20and%20in%20vivo&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-0367&volume=66&pages=8731-8739&publication_year=2006&author=Shoemaker%2CAR&author=Oleksijew%2CA&author=Bauch%2CJ
- How much does https://doi.org/10.1016%2F0163-7258%2888%2990004-6 rake in every month?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3290910's earnings
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Metabolism%20of%20oxazaphosphorines&journal=Pharmacol%20Ther&doi=10.1016%2F0163-7258%2888%2990004-6&volume=37&pages=301-355&publication_year=1988&author=Sladek%2CNE have monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14707277 generate monthly?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Genistein%20sensitizes%20diffuse%20large%20cell%20lymphoma%20to%20CHOP%20%28cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20prednisone%29%20chemotherapy&journal=Mol%20Cancer%20Ther&volume=2&pages=1361-1368&publication_year=2003&author=Mohammad%2CRM&author=Al-Katib%2CA&author=Aboukameel%2CA&author=Doerge%2CDR&author=Sarkar%2CF&author=Kucuk%2CO?
- How much money does https://doi.org/10.2165%2F00003495-199958003-00006 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10711840 bring in?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Oral%20etoposide%20in%20lymphoma&journal=Drugs&doi=10.2165%2F00003495-199958003-00006&volume=58&issue=Suppl%203&pages=35-41&publication_year=1999&author=Greco%2CFA
- https://doi.org/10.1158%2F0008-5472.CAN-06-2203's total income per month
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17283153?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Influence%20of%20Bcl-2%20family%20members%20on%20the%20cellular%20response%20of%20small-cell%20lung%20cancer%20cell%20lines%20to%20ABT-737&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2203&volume=67&pages=1176-1183&publication_year=2007&author=Tahir%2CSK&author=Yang%2CX&author=Anderson%2CMG produce monthly?
- What's the financial intake of https://doi.org/10.1038%2Fsj.onc.1210166?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17173063
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=%E2%80%98Seed%E2%80%99%20analysis%20of%20off-target%20siRNAs%20reveals%20an%20essential%20role%20of%20Mcl-1%20in%20resistance%20to%20the%20small-molecule%20Bcl-2%2FBcl-xL%20inhibitor%20ABT-737&journal=Oncogene&doi=10.1038%2Fsj.onc.1210166&volume=26&pages=3972-3979&publication_year=2007&author=Lin%2CX&author=Morgan-Lappe%2CS&author=Huang%2CX?
- How much profit does https://doi.org/10.1016%2Fj.ccr.2006.10.006 generate?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17097560?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20apoptosis%20sensitivity%20and%20resistance%20to%20the%20BH3%20mimetic%20ABT-737%20in%20acute%20myeloid%20leukemia&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2006.10.006&volume=10&pages=375-388&publication_year=2006&author=Konopleva%2CM&author=Contractor%2CR&author=Tsao%2CT have monthly?
- Get to know what's the income of https://doi.org/10.1016%2Fj.ccr.2006.08.027
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17097561's gross income?
- Income figures for http://scholar.google.com/scholar_lookup?&title=The%20BH3%20mimetic%20ABT-737%20targets%20selective%20Bcl-2%20proteins%20and%20efficiently%20induces%20apoptosis%20via%20Bak%2FBax%20if%20Mcl-1%20is%20neutralized&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2006.08.027&volume=10&pages=389-399&publication_year=2006&author=Delft%2CMF&author=Wei%2CAH&author=Mason%2CKD
- Monthly income for https://doi.org/10.1517%2F14728222.11.3.363
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17298294 earning monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Myeloid%20cell%20leukemia-1%20as%20a%20therapeutic%20target&journal=Expert%20Opin%20Ther%20Targets&doi=10.1517%2F14728222.11.3.363&volume=11&pages=363-373&publication_year=2007&author=Mandelin%2CAM&author=Pope%2CRM is on a monthly basis
- How much profit does https://doi.org/10.1093%2Fcarcin%2Fbgp165 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19578044 rake in every month?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Cisplatin%20overcomes%20Bcl-2-mediated%20resistance%20to%20apoptosis%20via%20preferential%20engagement%20of%20Bak%3A%20critical%20role%20of%20Noxa-mediated%20lipid%20peroxidation&journal=Carcinogenesis&doi=10.1093%2Fcarcin%2Fbgp165&volume=30&pages=1517-1527&publication_year=2009&author=Kutuk%2CO&author=Arisan%2CED&author=Tezil%2CT&author=Shoshan%2CMC&author=Basaga%2CH?
- Earnings of https://doi.org/10.1158%2F1078-0432.CCR-07-1255
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18316580's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20rituximab%20is%20associated%20with%20chemotherapy%20resistance%20resulting%20from%20decreased%20Bax%20and%20Bak%20expression&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1255&volume=14&pages=1550-1560&publication_year=2008&author=Olejniczak%2CSH&author=Hernandez-Ilizaliturri%2CFJ&author=Clements%2CJL&author=Czuczman%2CMS make?
- Explore the financials of https://doi.org/10.1158%2F0008-5472.CAN-06-2184
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17283164 bring in?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Development%20of%20rituximab-resistant%20lymphoma%20clones%20with%20altered%20cell%20signaling%20and%20cross-resistance%20to%20chemotherapy&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2184&volume=67&pages=1270-1281&publication_year=2007&author=Jazirehi%2CAR&author=Vega%2CMI&author=Bonavida%2CB?
- What's the financial gain of https://doi.org/10.1038%2Fsj.bjc.6603762?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17473827
- What's http://scholar.google.com/scholar_lookup?&title=Bcl-2%20expression%20in%20rituximab%20refractory%20cutaneous%20B-cell%20lymphoma&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6603762&volume=96&pages=1540-1543&publication_year=2007&author=Wobser%2CM&author=Voigt%2CH&author=Eggert%2CAO's gross income?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11156256
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20addition%20of%20bryostatin%201%20to%20cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20and%20prednisone%20%28CHOP%29%20chemotherapy%20improves%20response%20in%20a%20CHOP-resistant%20human%20diffuse%20large%20cell%20lymphoma%20xenograft%20model&journal=Clin%20Cancer%20Res&volume=6&pages=4950-4956&publication_year=2000&author=Mohammad%2CRM&author=Wall%2CNR&author=Dutcher%2CJA&author=Al-Katib%2CAM generate?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8172820?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20chemoresistance%20by%20the%20Bcl-2%20oncoprotein%20in%20non-Hodgkin%E2%80%99s%20lymphoma%20and%20lymphocytic%20leukemia%20cell%20lines&journal=Ann%20Oncol&volume=5&issue=Suppl%201&pages=61-65&publication_year=1994&author=Reed%2CJC&author=Kitada%2CS&author=Takayama%2CS&author=Miyashita%2CT?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7655019?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20Bcl-xL%20can%20confer%20a%20multidrug%20resistance%20phenotype&journal=Blood&volume=86&pages=1903-1910&publication_year=1995&author=Minn%2CAJ&author=Rudin%2CCM&author=Boise%2CLH&author=Thompson%2CCB
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8781438
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Upregulated%20expression%20of%20BCL-2%20in%20multiple%20myeloma%20cells%20induced%20by%20exposure%20to%20doxorubicin%2C%20etoposide%2C%20and%20hydrogen%20peroxide&journal=Blood&volume=88&pages=1805-1812&publication_year=1996&author=Tu%2CY&author=Xu%2CFH&author=Liu%2CJ
- How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s00280-009-1232-1?format=refman&flavour=references produce monthly?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Scott%20Ackler have monthly?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Scott%20Ackler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20J.%20Mitten bring in?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20J.%20Mitten%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kelly%20Foster?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kelly%20Foster%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anatol%20Oleksijew bring in?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anatol%20Oleksijew%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marion%20Refici?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marion%20Refici%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stephen%20K.%20Tahir's financial summary
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stephen%20K.%20Tahir%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yu%20Xiao's earnings
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yu%20Xiao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christin%20Tse have?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christin%20Tse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20J.%20Frost's revenue stream
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20J.%20Frost%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stephen%20W.%20Fesik
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stephen%20W.%20Fesik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Saul%20H.%20Rosenberg?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Saul%20H.%20Rosenberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Steven%20W.%20Elmore earning monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Steven%20W.%20Elmore%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alexander%20R.%20Shoemaker have monthly?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alexander%20R.%20Shoemaker%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://static-content.springer.com/esm/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_MOESM1_ESM.pdf income
- Discover the revenue of https://s100.copyright.com/AppDispatchServlet?title=The%20Bcl-2%20inhibitor%20ABT-263%20enhances%20the%20response%20of%20multiple%20chemotherapeutic%20regimens%20in%20hematologic%20tumors%20in%20vivo&author=Scott%20Ackler%20et%20al&contentID=10.1007%2Fs00280-009-1232-1©right=Springer-Verlag&publication=0344-5704&publicationDate=2010-01-23&publisherName=SpringerNature&orderBeanReset=true
- What is the earnings of https://citation-needed.springer.com/v2/references/10.1007/s00280-009-1232-1?format=refman&flavour=citation?
- How much profit does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral make?
- How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research bring in each month?
- How much profit does https://www.springernature.com/gp/products generate?
- What's the profit of https://www.springernature.com/gp/librarians?
- Explore the financials of https://www.springernature.com/gp/societies
- How much does https://www.springernature.com/gp/partners rake in every month?
- What's the monthly income of https://www.springer.com/?
- Discover the revenue of https://www.nature.com/
- How much income does https://www.biomedcentral.com/ have?
- How much money does https://www.palgrave.com/ make?
- What's the financial outcome of https://www.apress.com/?
- How much revenue does https://www.springernature.com/gp/legal/ccpa generate?
- How profitable is https://www.springernature.com/gp/info/accessibility?
- Revenue of https://support.springernature.com/en/support/home
- How much income is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations earning monthly?
- Income figures for https://www.springernature.com/
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js
CDN Services {π¦}
- Crossref